ASSET - Analysing and Striking the Sensitivities of Embryonal Tumours 01.11.2010

The project focuses on "tackling human diseases through systems biology approaches" using a combination of state-of-the-art genomics, proteomics and mathematical modelling.

ASSET is a five-year European consortium initiated on the 1 November 2010. This Collaborative European FP7-HEALTH project focuses on "tackling human diseases through systems biology approaches" using a combination of state-of-the-art genomics, proteomics and mathematical modelling. ASSET's major goal is to identify mechanistically understood network vulnerabilities that can be exploited for new approaches to the diagnosis and treatment of highlyaggressive and devastating major paediatric tumours, including neuroblastoma (NB), medulloblastoma (MB) and Ewing sarcoma family tumours (ESFT).

The CCRI is a partner and initiator of this project. Prof. Heinrich Kovar, PhD, is the scientist in charge.

Logo of ASSET